SY-LB-57（Cat No.:I043308）is a selective inhibitor of the enzyme lysine-specific demethylase 1 (LSD1), which plays a crucial role in the regulation of gene expression through the removal of methyl groups from histones. LSD1 is involved in various cellular processes, including cell differentiation, proliferation, and epigenetic regulation. By inhibiting LSD1, SY-LB-57 can potentially alter gene expression patterns, offering therapeutic potential in treating cancers and neurodegenerative diseases where LSD1 activity is dysregulated. This compound is being studied for its ability to reverse abnormal epigenetic modifications and restore normal cellular function in disease states.